PAA 2.63% 19.5¢ pharmaust limited

Ann: Positive Interim Study Results from OLE Study in ALS, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,394 Posts.
    lightbulb Created with Sketch. 291
    I've really been sweating on these results and it's a definite surprise to the upside! Over 40% slowing of disease progression is brilliant. I reckon if we achieve above 30% in the next study we will get FDA approval. 40% really knocks it outta the park.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
0.005(2.63%)
Mkt cap ! $94.89M
Open High Low Value Volume
20.0¢ 20.0¢ 19.5¢ $32.55K 166.0K

Buyers (Bids)

No. Vol. Price($)
6 248409 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 98968 3
View Market Depth
Last trade - 12.09pm 03/10/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.